ArticleFrontiers in immunology2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Ann-Kathrin Hartmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it